Literature DB >> 13468816

A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis.

P H HENNEMAN, S WALLACH.   

Abstract

Entities:  

Keywords:  ANDROGENS/therapeutic use; CLIMACTERIC, FEMALE/complications; ESTROGENS/therapeutic use; OSTEOPOROSIS/therapy

Mesh：

Substances：

Year:  1957        PMID： 13468816     DOI： 10.1001/archinte.1957.00260110031005

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  20 in total

1.  Height loss predicts subsequent hip fracture in men and women of the Framingham Study.

Authors:  Marian T Hannan; Kerry E Broe; L Adrienne Cupples; Alyssa B Dufour; Margo Rockwell; Douglas P Kiel
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  THE STUDY OF OSTEOPOROSIS AND OSTEOMALACIA.

Authors:  G A ROSE
Journal:  Postgrad Med J       Date:  1964-03       Impact factor: 2.401

3.  Current concepts in osteoporosis.

Authors:  C H EPPS
Journal:  J Natl Med Assoc       Date:  1959-03       Impact factor: 1.798

4.  The effects of sex hormones in experimental osteoporosis in rats.

Authors:  R A CALDWELL
Journal:  Br J Exp Pathol       Date:  1962-04

5.  Stilboestrol, phenobarbitone, and diet in chronic duodenal ulcer. A factorial therapeutic trial.

Authors:  S C TRUELOVE
Journal:  Br Med J       Date:  1960-08-20

6.  OESTROGENS in osteoporosis.

Authors: 
Journal:  Br Med J       Date:  1958-05-03

7.  TISSUE building and protein anabolizers.

Authors: 
Journal:  Br Med J       Date:  1958-09-27

8.  Bone and ageing.

Authors:  J Dequeker
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

9.  Observations on the incidence, aetiology, and pathology of senile osteoporosis.

Authors:  R A CALDWELL
Journal:  J Clin Pathol       Date:  1962-09       Impact factor: 3.411

10.  Measurement of height: practical considerations for the study of osteoporosis.

Authors:  R J Coles; D G Clements; W D Evans
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.